Infect Drug Resist. 2021 Sep 02;14:3581-3588. doi: 10.2147/IDR.S324018. eCollection 2021.
Emergence of .
Infection and drug resistance
Sandip Patil, Hongyu Chen, Chunna Guo, Xiaoli Zhang, Pei-Gen Ren, Ngiambudulu M Francisco, Feiqiu Wen
Affiliations
Affiliations
- Shenzhen Institute of Advanced Technology, Shenzhen University Town, Shenzhen, Guangdong Province, People's Republic of China.
- Department of Haematology and Oncology, Shenzhen Children's Hospital, Shenzhen, Guangdong Province, People's Republic of China.
- Paediatric Research Institute, Shenzhen Children's Hospital, Shenzhen, Guangdong Province, People's Republic of China.
- Department of Laboratory Medicine, Shenzhen Children's Hospital, Shenzhen, Guangdong Province, People's Republic of China.
- Grupo de Investigação Microbiana e Imunológica, Instituto Nacional de Investigação em Saúde (National Institute for Health Research), Luanda, Angola.
PMID: 34511949
PMCID: PMC8422287 DOI: 10.2147/IDR.S324018
Abstract
AIM: We investigated the clonal diversity of carbapenemase-producing
METHODS: From January 2014 to December 2018, a total number of 36 unique carbapenemase-producing clinical isolates of
RESULTS: The isolates showed resistance to ceftazidime, ertapenem, ampicillin, cefazolin, ceftriaxone, cefotetan, ticarcillin, cefaclor, cefpodoxime, azlocillin, cefcapene, mezlocillin and ampicillin-sulbactam. Of the 36
CONCLUSION: This study reports on the occurrence and spread of carbapenemase and extended-spectrum β-lactamase encoding genes co-existence in sporadic
© 2021 Patil et al.
Keywords: ESBLs; Klebsiella pneumoniae; antimicrobial susceptibility; carbapenemase; molecular characterization
Conflict of interest statement
The authors report no conflicts of interest in this work.
References
- Emerg Infect Dis. 2011 Oct;17(10):1791-8 - PubMed
- Front Microbiol. 2016 Jun 13;7:895 - PubMed
- PLoS One. 2019 Feb 13;14(2):e0209609 - PubMed
- Lancet Infect Dis. 2010 Dec;10(12):832 - PubMed
- Epidemiol Infect. 2015 Jan;143(2):376-84 - PubMed
- Sci Rep. 2019 Jan 24;9(1):696 - PubMed
- Eur J Clin Microbiol Infect Dis. 2016 Apr;35(4):611-8 - PubMed
- Infect Drug Resist. 2018 Oct 24;11:1935-1943 - PubMed
- Infect Drug Resist. 2021 Jul 23;14:2843-2849 - PubMed
- Antibiotics (Basel). 2021 Apr 20;10(4): - PubMed
- Clin Lab. 2020 Mar 1;66(3): - PubMed
- J Antimicrob Chemother. 2016 Jan;71(1):63-70 - PubMed
- PLoS One. 2015 Jul 15;10(7):e0132936 - PubMed
- Sci Rep. 2019 Feb 20;9(1):2392 - PubMed
- Lancet Infect Dis. 2013 Sep;13(9):785-96 - PubMed
- Antimicrob Agents Chemother. 2011 May;55(5):2420-3 - PubMed
- J Antimicrob Chemother. 2010 Mar;65(3):490-5 - PubMed
- Antimicrob Agents Chemother. 2011 May;55(5):2493-4 - PubMed
- J Microbiol Methods. 2005 Dec;63(3):219-28 - PubMed
- Emerg Infect Dis. 2017 Nov;23(11):1872-1875 - PubMed
- Clin Infect Dis. 2018 Nov 13;67(suppl_2):S263-S265 - PubMed
- Microb Drug Resist. 2013 Aug;19(4):295-7 - PubMed
- Infect Drug Resist. 2021 May 25;14:1931-1939 - PubMed
- Future Microbiol. 2018 Jun 1;13:771-783 - PubMed
- Clin Microbiol Infect. 2016 Mar;22 Suppl 1:S9-14 - PubMed
- Antimicrob Agents Chemother. 2017 Jul 25;61(8): - PubMed
- Int J Environ Res Public Health. 2013 Jul 01;10(7):2720-31 - PubMed
- Antimicrob Agents Chemother. 1994 Jun;38(6):1262-70 - PubMed
- J Antimicrob Chemother. 2017 May 1;72(5):1340-1349 - PubMed
- Antimicrob Agents Chemother. 2015 Jul;59(7):4349-51 - PubMed
- PLoS One. 2012;7(3):e33530 - PubMed
- Diagn Microbiol Infect Dis. 2011 May;70(1):119-23 - PubMed
- PLoS One. 2015 Mar 23;10(3):e0123690 - PubMed
- Crit Care. 2008;12 Suppl 4:S3 - PubMed
- Ann Lab Med. 2017 Sep;37(5):398-407 - PubMed
- Emerg Infect Dis. 2020 Jun;26(6):1212-1220 - PubMed
- PLoS One. 2015 Aug 11;10(8):e0135044 - PubMed
- Curr Opin Microbiol. 2018 Oct;45:131-139 - PubMed
- Am J Infect Control. 2015 Oct 1;43(10):1122-4 - PubMed
- Arch Argent Pediatr. 2019 Feb 1;117(1):6-11 - PubMed
Publication Types